SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 82 filers reported holding SEELOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $36,507 | +72.9% | 30,550 | 0.0% | 0.00% | – |
| Q1 2023 | $21,110 | -50.4% | 30,550 | -51.2% | 0.00% | – |
| Q4 2022 | $42,538 | -34.6% | 62,648 | 0.0% | 0.00% | – |
| Q3 2022 | $65,000 | +51.2% | 62,648 | 0.0% | 0.00% | – |
| Q2 2022 | $43,000 | -4.4% | 62,648 | +17.5% | 0.00% | – |
| Q1 2022 | $45,000 | -53.6% | 53,327 | -10.6% | 0.00% | – |
| Q4 2021 | $97,000 | -28.7% | 59,663 | +5.6% | 0.00% | – |
| Q3 2021 | $136,000 | -81.8% | 56,503 | -80.0% | 0.00% | – |
| Q2 2021 | $746,000 | – | 282,683 | +282583.0% | 0.00% | – |
| Q2 2019 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 508,000 | $249,000 | 0.10% |
| 1492 Capital Management LLC | 150,000 | $74,000 | 0.09% |
| Uniplan Investment Counsel, Inc. | 2,069,121 | $1,014,000 | 0.08% |
| ARDSLEY ADVISORY PARTNERS LP | 70,000 | $34,000 | 0.01% |
| Spark Investment Management LLC | 35,210 | $17,000 | 0.01% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 191,000 | $94,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $15,000 | 0.00% |
| Procyon Advisors, LLC | 2,500 | $1,000 | 0.00% |
| Renaissance Technologies | 1,078,379 | $529,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |